pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

10,169 catalysts · 3,128 8k filing · 2,096 grant · 1,160 approval · 1,000 device adverse event · 874 device 510k · 623 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 21 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-06×clear all
type
  • 8k filing3,128
  • grant2,096
  • approval1,160
  • device adverse event1,000
  • device 510k874
  • device pma623
earnings
584
  • device recall403
  • recall220
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 12, 2026

    36
    ›Jan 16, 2026grant208d agoUNIVERSITY OF FLORIDA — Investigating the roles of extracellular pyruvate in regulating Streptococcus...University of Florida

    DE grant. $419,375. PI: Kelly Christine Rice

    full page →nih reporter ↗
    ›Jan 16, 2026grant208d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — A Synaptic Basis for Dopamine-Driven Reinforcement Learning in Cortex

    NS grant. $126,900. PI: Eddy Albarran

    full page →nih reporter ↗
    ›Jan 16, 2026grant208d agoSMITH-KETTLEWELL EYE RESEARCH INSTITUTE — Computational Modelling of Perceptual Information Accumulation in Blind Indiv...

    EY grant. $76,120. PI: Sofia Krasovskaya

    full page →nih reporter ↗
    ›Jan 16, 2026grant208d agoYALE UNIVERSITY — Investigating the Role of Epstein-Barr Virus in Long COVID Pathogenesis

    AI grant. $33,538. PI: Alexandra Tabachnikova

    full page →nih reporter ↗
    ›Jan 16, 2026grant208d agoCHILDREN'S HOSP OF PHILADELPHIA — Microfracture-based Repair for Temporomandibular Joint Osteoarthritis

    DE grant. $78,840. PI: Hagar Kenawy

    full page →nih reporter ↗
    ›Jan 16, 2026grant208d agoBOSTON CHILDREN'S HOSPITAL — Dissecting Neural Circuits for Top-Down Control of Sympathetic FunctionsBoston Children's Hospital

    NS grant. $674,950. PI: ZHIGANG HE

    full page →nih reporter ↗
    ›Jan 16, 2026grant208d agoTEMPLE UNIV OF THE COMMONWEALTH — Voice-activated antibacterial piezoelectric composites for dental restorations

    DE grant. $435,875. PI: Santiago Orrego

    full page →nih reporter ↗
    ›Jan 16, 2026grant208d agoBROWN UNIVERSITY — Investigating the Role of AIMP2 in Cardiac Stress Responses

    HL grant. $49,538. PI: Vasundhara Singh

    full page →nih reporter ↗
    ›Jan 17, 2026approval207d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoPOTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (POTASSIUM CHLORIDE) — FDA approvalUpsher-Smith Laboratories LLC

    Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval207d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026device 510k207d agoMedtronic, Ireland — Sprinter Legend Rapid Exchange Balloon Dilatation Catheter (510k cleared)

    Product code: LOX. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 17, 2026device 510k207d agoAuxilium Biotechnologies, Inc. — NeuroSpan Bridge (510k cleared)AXIM BIOTECHNOLOGIES, INC.

    Product code: JXI. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 17, 2026grant207d agoHARVARD UNIVERSITY — From Exploration to Expertise: Mechanisms of Motor Learning in Cortico-Basal ...

    NS grant. $120,582. PI: Kiah Hardcastle

    full page →nih reporter ↗
    ›Jan 18, 2026approval206d agoTOPIRAMATE — FDA approvaltopiramate ER

    Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL

    full page →topiramate ER →fda approvals ↗
    ›Jan 18, 2026approval206d agoAMBRISENTAN — FDA approvalSigmapharm Laboratories LLC

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 18, 2026approval206d agoAMBRISENTAN — FDA approvalSigmapharm Laboratories LLC

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 18, 2026approval206d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: MYLAN. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Jan 18, 2026approval206d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

    Sponsor: AMTA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 18, 2026device 510k206d agoBiosense Webster, Inc. — CARTO™ 3 EP Navigation System V9.0 with PIU Plus (510k cleared)

    Product code: DQK. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Jan 18, 2026device 510k206d agoBaylis Medical Technologies, Inc. — Baylis Connector Cable (510k cleared)Medical Care Technologies Inc.

    Product code: DSA. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Jan 18, 2026grant206d agoDUKE UNIVERSITY — Mechanisms of the small nucleolar RNA Snord67 in breast cancer lymphatic meta...Duke University

    CA grant. $87,964. PI: Katherine Ismei Zhou

    full page →nih reporter ↗

    Week of Jan 19, 2026

    14
    ›Jan 19, 2026approval205d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Jan 19, 2026approval
    ← prev
    page 11 of 204
    next →
    205d ago
    AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Jan 19, 2026approval205d agoGLYCOPYRROLATE — FDA approvalFresenius Kabi USA LLC

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 19, 2026approval205d agoGLYCOPYRROLATE — FDA approvalFresenius Kabi USA LLC

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 19, 2026grant205d agoGORDON RESEARCH CONFERENCES — 2026 Bones and Teeth Gordon Research Conference and Gordon Research Seminar

    AR grant. $15,000. PI: JOY Y WU

    full page →nih reporter ↗
    ›Jan 20, 2026approval204d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Jan 20, 2026approval204d agoMIRABEGRON — FDA approvalAstellas Pharma US Inc

    Sponsor: ALKEM LABS LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval204d agoZIRGAN (GANCICLOVIR) — FDA approvalganciclovir

    Sponsor: BAUSCH AND LOMB. Form: GEL. Route: OPHTHALMIC

    full page →ganciclovir →fda approvals ↗
    ›Jan 20, 2026approval204d agoSERTRALINE HYDROCHLORIDE — FDA approvalGreenstone LLC

    Sponsor: UMEDICA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval204d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval204d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval204d agoSERTRALINE HYDROCHLORIDE — FDA approvalSERTRALINE HYDROCHLORIDE

    Sponsor: NOVITIUM PHARMA. Form: CAPSULE. Route: ORAL

    full page →SERTRALINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 20, 2026approval204d agoMOUNJARO (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Jan 20, 2026approval204d agoMETHYLPREDNISOLONE ACETATE — FDA approvalMETHYLPREDNISOLONE ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

    full page →METHYLPREDNISOLONE ACETATE →fda approvals ↗
    $MDCE0.00020.00%
    $AXIM
    $LLY1215.02-1.37%
    $PYPD4.7300-0.84%
    $PYPD4.7300-0.84%
    $LLY1215.02-1.37%
    $BLCO16.87+0.24%